Background {#Sec1}
==========

*Staphylococcus aureus* is the leading cause of nosocomial and community-associated infections, which is responsible for a wide variety of infections that include mild superficial skin infections, osteomyelitis, implant-associated heart valve, native valve endocarditis, severe sepsis and bacteremia \[[@CR1]\]. If infections caused by *S. aureus* are not effectively treated, high mortality in some patients could occur \[[@CR2]\]. Although antibiotic resistance is a major problem in treatment of infections caused by *S. aureus*, drug-tolerant persisters such as small colony variants (SCVs) are demonstrated to be significant contributors of chronic persistent infections and recurrent infections \[[@CR3]\]. Persisters are non-growing or slow growing antibiotic-tolerant bacterial cells that are able to revert to growing forms under appropriate conditions and cause relapse or persistent infections with symptoms \[[@CR4], [@CR5]\]. Clinically, infections caused by *S. aureus* such as soft tissue infections, endocarditis, osteomyelitis, prosthetic joint infections, and biofilm-related infections on indwelling device is difficult to cure with the current antibiotics, which are mainly active against the growing bacteria but have poor activity against the non-growing persisters \[[@CR6]\]. Recently, it has been shown that a drug combination approach using drugs targeting both log phase growing bacteria and the non-growing stationary phase bacteria could more effectively eradicate a persistent urinary tract infection and a biofilm skin infection in the mouse models \[[@CR4], [@CR7]--[@CR9]\]. However, the choice of persister drugs is limited at present, and treatment of persistent infections remains a challenge.

Essential oils are concentrated volatile liquids extracted from plants. They are widely used in food processing, aromatherapy and also in medical therapy especially with recent concerns on anti-bacteria activity \[[@CR10]\]. Many studies reveal that essential oils have antibacterial activity against both Gram-negative and Gram-positive bacteria \[[@CR11]\]. In addition, various compositions of essential oils including eugenol, carvacrol and thymol have been demonstrated to be active against different bacterial species \[[@CR12]\]. Although some essential oils were found to be active against growing *S. aureus* \[[@CR11], [@CR13], [@CR14]\], the activity of essential oils against non-growing stationary phase *S. aureus* has not been studied. Because activity against non-growing persisters or stationary phase bacteria correlates with in vivo activity against persistent infections in the case of uropathogenic *E. coli* and *B. burgdorferi* persistent infections \[[@CR7], [@CR9], [@CR15], [@CR16]\], here, we evaluated a panel of 143 essential oils for their activity against stationary phase *S. aureus* as a model for activity against persisters \[[@CR6], [@CR17]\]. We identified a range of highly potent essential oils with excellent activity against non-growing stationary phase *S. aureus.*

Methods {#Sec2}
=======

Bacterial strain and culture conditions {#Sec3}
---------------------------------------

*S. aureus* strain Newman, a commonly used pan-susceptible strain isolated from a patient suffering from osteomyelitis \[[@CR6]\], was used in this study. The strain was grown in Tryptic Soy Broth (TSB) medium without shaking at 37 °C, 5% CO~2~ overnight and the culture was regarded as stationary phase *S. aureus* culture according to our previous study \[[@CR6]\]. The overnight stationary phase *S. aureus* culture (\~ 10^9^ CFU/mL) was used directly without dilution for essential oil screens and drug exposure tests.

Antibiotics and essential oils {#Sec4}
------------------------------

Tosufloxacin, ciprofloxacin, levofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin were purchased from Sigma-Aldrich (St. Louis, MO, USA) and dissolved in dimethyl sulfoxide (DMSO) or H~2~O to form 10 mg/mL or 100 mM stock solutions \[[@CR3], [@CR9], [@CR10]\]. All antibiotic stocks (except DMSO stocks) were filter-sterilized by 0.2 μm filter and stored at − 20 °C.

Commercially available essential oils were purchased from Natural Acres (MO, USA), Plant Therapy (ID, USA) and Plant Guru (NJ, USA). More information about the essential oils can be found on their websites (<http://www.theplantguru.com/gc-ms-testing>, <http://www.planttherapy.com/essential-oils>, <http://naturalacresoils.com/collections/all>). The main chemical compositions of active essential oils are summarized in Table [S1](#MOESM1){ref-type="media"} based on manufacturer's GC-MS reports or literature. DMSO-soluble essential oils were dissolved in DMSO at 5% (v/v). DMSO-insoluble essential oils were directly added to *S. aureus* cultures, then vortexed to form aqueous suspension \[[@CR12]\]. The 5% essential oils or aqueous suspension were further diluted into the bacterial cultures to achieve desired dilution in the following drug exposure or MIC experiments to evaluate their activity against non-growing stationary phase or growing log phase *S. aureus*.

Screening of essential oils for their activity against stationary phase *S. aureus* {#Sec5}
-----------------------------------------------------------------------------------

To evaluate the effect of essential oils on stationary phase bacteria, the essential oils and drugs were added to the 96-well plates containing stationary phase bacteria, leaving the first and last columns in each plate blank for control. Firstly, 20 μL 5% essential oil stocks were added to the 96-well plate containing 180 μL of the overnight stationary phase *S. aureus* culture to obtain the desired concentration of 0.5%. Then, the 0.25% treatment concentration was obtained by mixing 100 μL 0.5% essential oil culture mixture with 100 μL stationary phase culture. Finally, the 0.125% concentration was prepared as described above \[[@CR12]\]. Tosufloxacin, ciprofloxacin, levofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin were used at 50 μM as control antibiotics. The plates were incubated at 37 °C, 5% CO~2~ without shaking. After 3 days and 5 days of exposure to essential oils or drugs, the bacterial suspension was transferred to TSB plates with a 96-pin replicator to monitor the bacterial survival and regrowth after further incubation at 37 °C. All tests were run in triplicate.

Antibiotic susceptibility test {#Sec6}
------------------------------

The minimum inhibitory concentrations (MICs) were determined using microdilution method according to the CLSI guideline \[[@CR18]\]. Essential oils were 2-fold diluted from 1 to 0.0075%. Gentamicin was 2-fold diluted from 512 μg/mL to 0.25 μg/mL as a control antibiotic. The 96-well plates were sealed and incubated at 37 °C overnight without shaking. Then the bacterial culture was observed to determine the MIC that inhibited the visible growth of *S. aureus.* All experiments were run in triplicate.

Validation of active essential oils by colony forming unit (CFU) assay {#Sec7}
----------------------------------------------------------------------

Based on the results of primary screening assay, active essential oils were further confirmed by colony forming unit (CFU) assay \[[@CR3], [@CR9], [@CR10], [@CR12]\]. Briefly, the stationary phase bacteria were transferred into Eppendorf tubes for drug exposure experiment, which were treated with 0.25 and 0.125% active essential oils, respectively. Tosufloxacin, ciprofloxacin, levofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin were added to bacterial suspensions at the final concentration of 20 μM, respectively. At different time points, 100 μL bacterial suspensions were collected by centrifugation, washed and resuspended in PBS. After serial dilutions, 10 μL of each dilution was plated on TSB plate for CFU count.

Drug combination assay on stationary phase *S. aureus* {#Sec8}
------------------------------------------------------

In this study, we used Oregano as the common element to test the activity of various two-drug combinations in killing *S. aureus* Newman stationary phase cells. We evaluated tosufloxacin, levofloxacin, ciprofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin at the final concentration of 5 μg/mL in combination with Oregano (0.025%). The designed drug combinations or single drug controls were added directly to stationary phase culture. At each time point, the bacterial suspensions were collected by centrifugation and washed twice with PBS buffer. Then the cell suspension was serially diluted and plated on TSB agar plates for CFU counts as above. No drug added stationary phase culture was included as a drug-free control.

Results {#Sec9}
=======

Identification of active essential oils against stationary phase *S. aureus* {#Sec10}
----------------------------------------------------------------------------

Consistent with our previous study \[[@CR6]\], tosufloxacin was shown to have high activity against stationary phase *S. aureus*, while other clinical drugs including ciprofloxacin, levofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin were not able to completely kill stationary phase *S. aureus* at 50 μM after five-day drug exposure \[[@CR8]\]. Interestingly, after three-day exposure, 30 (Cinnamon bark, Oregano, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Bandit "Thieves", Sandalwood oil, Health shield, Allspice, Amyris, Palmarosa, Cinnamon leaf, Clove bud, Citronella, Geranium bourbon, Marjoram, Peppermint, Lemongrass (*Cymbopogon citratus*), Cornmint, Elemi, Ho wood, Head ease, Lemon eucalyptus, *Litsea cubeba*, Myrrh, Parsley seed, Coriander oil, Dillweed, Hyssop, Neroli, Rosewood oil), 6 (Cinnamon bark, Oregano, Thyme white, Bandit "Thieves", Lemongrass (*Cymbopogon flexuosus*), Sandalwood oil) and 7 (Cinnamon bark, Oregano, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Allspice, Amyris, Palmarosa) essential oils were found to have high activity against stationary phase *S. aureus* at 0.5, 0.25 and 0.125% concentrations, respectively. When the drug exposure was extended to 5 days, additional 9 essential oils (Tea tree, Cajeput, Clove bud, Lavender, Sleep tight, Vetiver, Palo santo, Sage oil, Yarrow) and 4 essential oils (Health shield, Allspice, Amyris, Palmarosa) were found to be active at 0.5 and 0.25% concentration, respectively (Table [1](#Tab1){ref-type="table"}). The top 10 essential oils (Cinnamon bark, Oregano, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Bandit "Thieves", Sandalwood oil, Health shield, Allspice, Amyris, Palmarosa), which showed high activity at 0.25% concentration, were used in the subsequent testing to confirm their activity in inhibiting growth of *S. aureus* in MIC test and in CFU drug exposure assay for their activity against non-growing stationary phase *S. aureus*. Table 1Effect of essential oils on stationary phase *Staphylococcus aureus*EO ^**a**^PlantViability of bacteria after 3 or 5 days of exposure ^**b**^0.5% EO ^**a**^0.25% EO ^**a**^0.125% EO ^**a**^3 days5 days3 day5 days3 day5 daysAllspice*Pimenta officicalis*----+------Amyris*Amycris balsamifera*----+------Bandit "Thieves"Synergy blend--------++Cajeput*Melaleuca cajeputi*+--++++Cinnamon bark*Cinnamomum zeylanicum*------------Cinnamon leaf*Cinnamomum zeylanicum*----++++Citronella*Cymbopogon winterianus*----++++Clove bud*Eugenia caryophyllata*----++++Coriander oil*Coriandrum sativum*----++++Cornmint*Menta arvensis*----++++Dillweed*Anethum graveolens*----++++Elemi*Canarium iuzonicum*----++++Geranium bourbon*Pelargonium graveolens*----++++Clove Bud*Syzygium aromaticum*+--++++Head easeSynergy blend----++++Health shieldSynergy blend----+--++Ho wood*Cinnamomum camphora*----++++Hyssop*Hyssopus officinalis*----++++Lavender*Lavendula officianalis*+--++++Lemon eucalyptus*Eucalyptus citriadora*----++++Lemongrass*Cymbopogon citratus*----++++*Litsea cubebaLitsae cubeba*----++++Marjoram (Sweet)*Origanum marjorana*----++++Myrrh*Commiphora myrrha*----++++Neroli*Citrus aurantium*----++++Oregano*Origanum vulgare*------------Palmarosa*Cymbopogon martinii*----+------Palo Santo*Bursera graveolens*+--++++Parsley seed*Petroselinum sativum*----++++Peppermint*Mentha piperita*----++++Rosewood oil*Aniba rosaeodora*----++++Sage oil*Salvia officinalis*+--++++Sandalwood oil*Santalum spicatum*--------++Sleep tightSynergy blend+--++++Tea Tree*Melaleuca alternifolia*+--++++Thyme white*Thymus zygis*------------Vetiver*Vetiveria zizanoides*+--++++Yarrow*Achillea millefolium*+--++++^a^ "EO" essential oil^b^ "-" No obvious colonies grew on TSB plate after drug exposure; "+" Obvious colonies were found on TSB plate after drug exposure

MIC determination of the top active essential oils {#Sec11}
--------------------------------------------------

We carried out antibiotic susceptibility testing to determine the activity of the top 10 active essential oils against growing *S. aureus*. As shown in Table [2](#Tab2){ref-type="table"}, Oregano, Amyris and Sandalwood oil were the most active agents in inhibiting the growth of *S. aureus*, with the lowest MIC of 0.015% in our study. The growth of *S. aureus* was efficiently suppressed by Cinnamon bark at 0.03%. Allspice could inhibit the growth of *S. aureus* with an MIC of 0.06%, while Thyme white, Health shield, Bandit "Thieves", Lemongrass (*Cymbopogon flexuosus*) and Palmarosa had the same MIC of 0.125% against *S. aureus*. Clinical drug gentamicin included as a control inhibited the growth of *S. aureus* with an MIC of 1 μg/mL. Table 2Activity of top 10 essential oils that are active against stationary phase *Staphylococcus aureus* in terms of their activity against growing bacteria (MIC) and non-growing bacteria in drug exposureDrug /essential\
oilPlantMIC (μg/mL /%)Viability of bacteria after 3 or 5 days of EO ^**b**^ exposure (0.25%) ^**c**^3 day5 daysGentamicin ^a^--1++Sandalwood oil*Santalum spicatum*0.015----Amyris*Amycris balsamifera*0.015+--Oregano*Origanum vulgare*0.015+--Cinnamon bark*Cinnamomum zeylanicum*0.03----Allspice*Pimenta officicalis*0.06+--Thyme white*Thymus zygis*0.125----Health shield*Cassia, clove, eucalyptus, lemon and rosemary*0.125+--Bandit "Thieves"*cloves, cinnamon, lemon, rosemary and eucalyptus*0.125----Lemongrass*Cymbopogon flexuosus*0.125----Palmarosa*Cymbopogon martinii*0.125+--^a^ The concentration of gentamicin used in drug exposure was 50 μM; ^b^ "EO" essential oil; ^**c**^ "-" No obvious colonies grew on TSB plate after drug exposure; "+" Obvious colonies were found on TSB plate after drug exposure

Comparison of active essential oils in their ability to kill stationary phase *S. aureus* {#Sec12}
-----------------------------------------------------------------------------------------

We first tested the activity of tosufloxacin and other clinically used drugs against stationary phase *S. aureus* at 20 μM. As previously described \[[@CR6]\], tosufloxacin could kill all stationary phase *S. aureus* cells after seven-day drug exposure, with no visible colonies on TSB agar plate. Levofloxacin, ciprofloxacin and rifampin had weak activity with 10^4^\~10^5^ CFU/mL cells remaining after seven-day exposure. In contrast, other clinical drugs including linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin did not show obvious activity against stationary phase *S. aureus* even when the drug exposure was extended to 7 days (Fig. [1](#Fig1){ref-type="fig"}). In contrast, eight essential oils (Cinnamon bark, Oregano, Thyme white, Bandit "Thieves", Lemongrass (*Cymbopogon flexuosus*), Health shield, Allspice, Palmarosa) at 0.25% concentration could eradicate all stationary phase cells after one-day exposure. Meanwhile, Amyris could clear all the cells after three-day exposure whereas Sandalwood oil could not eradicate the stationary phase *S. aureus* cells after seven-day exposure. At a lower concentration of 0.125%, we noticed that Oregano, Lemongrass (*Cymbopogon flexuosus*) and Thyme white still exhibited strong activity against stationary phase *S. aureus*, and no CFU could be detected after one-day exposure (Fig. [2](#Fig2){ref-type="fig"}). Meanwhile, Cinnamon bark, Allspice, Amyris and Palmarosa could eradicate stationary phase *S. aureus* cells after three-day exposure. On the other hand, Bandit "Thieves", Sandalwood oil and Health shield could not eradicate the stationary phase *S. aureus* culture even when exposure time was extended to 7 days. Fig. 1Activity of tosufloxacin and commonly used antibiotics against stationary phase *S. aureus*. Tosufloxacin had good anti-persister activity against *S. aureus* as expected, while antibiotics commonly used to treat *S. aureus* infections had poor activity against the stationary phase bacteria. The final concentration of antibiotics including tosufloxacin, ciprofloxacin, levofloxacin, rifampin, linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin and gentamicin, was all 20 μM. Sulfamethoxazole-trimethoprim is the combination of trimethoprim and sulfamethoxazole in a ratio of 5:1Fig. 2Activity of active essential oil candidates (0.125%) against stationary phase *S. aureus*. Oregano, Lemongrass (*Cymbopogon flexuosus*) and Thyme white could eradicate all stationary phase cells after one-day exposure. Cinnamon bark, Allspice, Amyris and Palmarosa could eradicate stationary phase *S. aureus* cells after three-day exposure. Bandit "Thieves", Sandalwood oil and Health shield still could not eradicate the *S. aureus* stationary phase culture even after five-day exposure

Development of essential oil drug combinations to eradicate stationary phase *S. aureus* in vitro {#Sec13}
-------------------------------------------------------------------------------------------------

It has been reported that synergistic activity between antibiotic and essential oil could occur, which achieved better bactericidal effect against growing *S. aureus* \[[@CR19]\]*.* It is of great importance to include drugs that target persister bacteria in the treatment of infection diseases \[[@CR7]\]. Based on our results, Oregano demonstrated high activity against not only log phase growing *S. aureus* with a low MIC but also stationary phase non-growing bacteria. Meanwhile, clinically used drugs had limited activity to kill *S. aureus* persisters. To more effectively eradicate the stationary phase *S. aureus*, we evaluated essential oil drug combinations using clinical drugs in combination with Oregano (0.025%). We found that some essential oil drug combinations were indeed much more effective than single drugs (Fig. [3](#Fig3){ref-type="fig"}). Among them, rifampin + Oregano could completely eradicate all the stationary phase *S. aureus* after just one-day exposure. Tosufloxacin + Oregano could eradicate all stationary phase cells after three-day exposure. Meanwhile, levofloxacin + Oregano and ciprofloxacin + Oregano could kill all the stationary phase *S. aureus* after five-day exposure. These drug combinations showed much better activity than respective single drugs (10^4^ \~ 10^6^ CFU/mL cells remaining) and somewhat better activity than Oregano alone (10^4^ CFU/mL remaining). In contrast, other essential oil drug combinations such as linezolid + Oregano, vancomycin + Oregano, sulfamethoxazole + Oregano, trimethoprim + Oregano, azithromycin + Oregano and gentamicin + Oregano had limited activity against stationary phase cells, with 10^4^ CFU/mL bacterial cells remaining even after five-day exposure, suggesting these combinations were not significantly better than Oregano alone (10^4^ CFU/mL remaining). Fig. 3Comparison of the activity of Oregano in combination with different antibiotics against stationary phase *S. aureus*. Effects of ciprofloxacin, levofloxacin, tosufloxacin, rifampin alone and their combinations with Oregano are presented in (A). Effects of linezolid, vancomycin, sulfamethoxazole, trimethoprim, azithromycin, gentamicin and their combinations with Oregano are presented in (B). The final concentration of antibiotics is 5 μg/mL and the concentration of Oregano is 0.025%

Discussion {#Sec14}
==========

*S. aureus* is known to give rise to a diverse range of infections from mild skin infections to serious diseases such as endocarditis and osteomyelitis and biofilm infections. Persisters are dormant phenotypic variants of bacterial cells that are tolerant to antibiotics and genetically identical drug susceptible kin \[[@CR20]\]. Since persisters were first identified in 1944 \[[@CR21]\], there is considerable evidence that drug-tolerant persisters are the contributors to persistent and relapsing infections \[[@CR20], [@CR22], [@CR23]\], Meanwhile, treatment of persistent *S. aureus* infections has remained a challenge. It has been proposed that use of persister drugs against non-growing bacteria in combinations with antibiotics or drugs active against growing bacteria as in the Yin-Yang model can provide a more effective treatment of persistent infections \[[@CR4]\]. Although a previous study has screened FDA-approved drug library to identify agents that have good activity against stationary phase *S. aureus* \[[@CR6]\], only a few useful hits such as tosufloxacin and clinafloxacin were identified. Although ADEP4, an experimental acyldepsipeptide antibiotic killing *S. aureus* persisters in combination with rifampin has been reported to cure a deep wound infection in a mouse model \[[@CR24]\], its validity in treating persistent *S. aureus* infections and in other persistent infection models remains to be confirmed. Thus, while it is of great importance to include drugs targeting persister bacteria in the treatment of *S. aureus* infections, the choice of persister drugs that may be useful is quite limited. Since most studies of essential oil activity on *S. aureus* were performed on log phase growing bacteria \[[@CR11], [@CR13]\], here we set out to determine the activity of a large panel of essential oils against stationary phase *S. aureus* cultures enriched in persister bacteria. Interestingly, we identified a range of essential oils, some of which are newly identified in this study, that have strong activity against stationary phase cultures of *S. aureus* that may be useful for more effective treatment of persistent *S. aureus* infections.

While there are some reports on activity of essential oils against log phase *S. aureus*, the number of evaluated essential oils is small (just one or two kinds of essential oils) \[[@CR11], [@CR14]\], and their activity against stationary phase *S. aureus* cultures has not been studied \[[@CR11], [@CR14]\]. In this study, we evaluated a panel of 143 essential oils for their activity against stationary phase *S. aureus.* We identified 9 essential oils (at 0.25% concentration) that are more active than persister drug tosufloxacin (20 μM), a quinolone drug control that could eradicate stationary phase *S. aureus* \[[@CR6]\]. Among them, 7 essential oils (Oregano, Cinnamon bark, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Allspice, Amyris, Palmarosa) showed outstanding activity against stationary phase *S. aureus* at 0.125% concentration (Fig. [2](#Fig2){ref-type="fig"}). The MIC is used to measure activity of a compound against growing bacteria \[[@CR25]\], however, compounds or drugs with low MICs do not translate into activity against non-growing bacteria. Interestingly, some essential oils have strong activity against both growing and non-growing bacteria. In this study, we found that the top 9 essential oils showed high activity against growing *S. aureus* with low MIC values (Table [2](#Tab2){ref-type="table"}) also had good activity against non-growing stationary phase bacteria. Some of active essential oils such as Thyme white, Oregano, Cinnamon bark and Lemongrass (*Cymbopogon flexuosus*), have been reported to have high activity against log phase *S. aureus* in previous studies \[[@CR13], [@CR26]--[@CR28]\], but we found these to be active against stationary phase *S. aureus* as well. More importantly, Bandit "Thieves", Health shield, Allspice, Amyris, Palmarosa were first reported in this study to have activity against both growing and non-growing stationary phase *S. aureus*. Compared with our previous work on activity of essential oils against stationary phase *E. coli*, some essential oils including Cinnamon bark, Oregano, Bandit "Thieves", Health shield and Allspice exhibited outstanding activity against both Gram-positive *S. aureus* and Gram-negative *E. coli* \[[@CR29]\], while it seems that Thyme white, Lemongrass (*Cymbopogon flexuosus*), Amyris, Palmarosa just showed high activity against *S. aureus* \[[@CR29]\]*,* while Cinnamon leaf, Clove bud and *Syzygium aromaticum* were only active against *E. coli* \[[@CR29]\]. Moreover, although some studies indicate that certain active essential oils including their main active components such as carvacrol or eugenol could induce membrane damage by causing loss of cellular contents \[[@CR15], [@CR30], [@CR31]\], there are limited studies available that focus on the active components and the mechanisms of antimicrobial action of essential oils in general. Here, we identified some active essential oils against stationary phase *S. aureus* and list their major compositions (Table [S1](#MOESM1){ref-type="media"})*.* Further studies are needed to determine the main active components and the mechanisms of action of the active essential oils identified in this study.

Oregano is known to be one of the most effective essential oils against a wide variety of pathogens, including *Pseudomonas sp*., *Salmonella sp*., *Escherichia coli* and *Borrelia burgdorferi* \[[@CR10], [@CR13]\]. In this study, Oregano exhibited high activity against log phase growing *S. aureus* strain Newman with a low MIC of 0.015%, which was almost equal to the MIC value (0.01%) for growing *S. aureus* strain ATCC 29213 \[[@CR7]\]. Meanwhile, Oregano exhibited its high activity against stationary phase non-growing bacteria with complete clearance without any regrowth at 0.125% concentration. Remarkably, when combined with some currently recommended antibiotics for *S. aureus* infections, Oregano showed a positive enhancement effect in increasing the activity of some antibiotics (quinolones, rifampin) against stationary phase *S. aureus* (Fig. [3](#Fig3){ref-type="fig"})*.* When combined with rifampin, the combination showed outstanding activity with 100% clearance after just one-day exposure. When combined with tosufloxacin and two other quinolone drugs (levofloxacin and ciprofloxacin), the combinations could wipe out all stationary phase cells after three-day or five-day exposure. The synergistic effect of Oregano and the four drugs may have implications for improved treatment of *S. aureus* persistent infections. Further studies should be carried out to confirm if such combination approaches are useful in animal models.

Additionally, we found Cinnamon bark, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Allspice, Amyris and Palmarosa showed excellent activity against stationary phase *S. aureus* at a low concentration of 0.125% (Fig. [2](#Fig2){ref-type="fig"}). Cinnamon bark was reported to have activity against bacteria, fungi, inflammation, cancer and diabetes \[[@CR32]\]. In this study, Cinnamon bark oil showed its remarkable activity against not only log phase growing *S. aureus* with a low MIC of 0.125% but also activity against non-growing stationary phase *S. aureus*. Thyme white, extracted from *Thymus zygis*, showed great activity against both log phase and stationary phase *S. aureus* at the same concentration of 0.125% (Table [1](#Tab1){ref-type="table"} and Table [2](#Tab2){ref-type="table"}). Essential oils obtained from *Thymus* species were often compared for their antibacterial and antioxidant activity. And oil from *Thymus zygis* was the most active one against log phase Gram-positive and Gram-negative bacteria \[[@CR26], [@CR33]\]. Our results highlighted its antibacterial activity not only against growing *S. aureus* bacteria but also non-growing stationary phase cells. The antibacterial effect of Thymus essential oils could be due to action of carvacrol or thymol or to a synergistic effect of its major and minor components \[[@CR32]\]. The observation that three different *Thymus* species of the same genus all possessed activity against log phase bacteria and one of which was demonstrated to be active against stationary phase bacteria provides justification to identify the active components active against stationary phase bacteria. Lemongrass from two different plants (*Cymbopogon flexuosus* and *Cymbopogon citratus*) were evaluated in this study. While Lemongrass from *Cymbopogon flexuosus* could kill all stationary phase *S. aureus* in just 1 day at 0.125%, Lemongrass from *Cymbopogon citratus* showed obvious activity only at a high concentration (0.5%). This provides the basis for further identification of active component and testing of *Cymbopogon flexuosus* in animal models of infection. Allspice is widely known as a popular spice in food processing \[[@CR34]\], here, its activity against *S. aureus* may facilitate its usage for antibacterial purpose. Compared with other essential oils, there are few studies discussing bioactivity of Amyris. One study revealed that vapor delivery of Amyris could alter pyrethroid efficacy and detoxification enzyme activity in mosquitoes \[[@CR35]\]. Our new finding of Amyris activity on *S. aureus* may contribute to more bioactivity of Amyris and therapeutic use of *Amyris balsamifera.* Palmarosa, known as *Cymbopogon martini*, is used in Ayurvedic medicine to relieve nerve pain for skin problems and as a skin tonic in aromatherapy due to its antimicrobial properties \[[@CR36]\]. While its immunomodulatory activity is based on geraniol \[[@CR36]\], the main component of Palmarosa active against stationary phase *S. aureus* is unknown and will be determined in the future.

Along with the essential oils with strong activity against *S. aureus* persisters at 0.125%, there were three essential oils (Bandit "Thieves", Sandalwood oil and Health shield) that showed obvious activity only at higher concentrations. Bandit "Thieves" and Health shield could eradicate all stationary phase cells after one-day exposure at 0.25% concentration. Both Bandit "Thieves" and Health shield are synergy blend of essential oils. While Bandit "Thieves" contains clove, cinnamon, lemon, rosemary and eucalyptus oils, Health shield is a mixture of essential oils from cassia, clove, eucalyptus, lemon and rosemary. They were active against growing *S. aureus* with the same MIC value of 0.125% and showed similar activity against non-growing stationary phase *S. aureus* cells (Table [2](#Tab2){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}). Sandalwood oil exhibited obvious activity against both growing and non-growing *S. aureus* in our initial screen with 96-pin replicator transfer test at 0.25% (Table [2](#Tab2){ref-type="table"}) but subsequent CFU assay revealed it showed activity only at a higher concentration of 0.5%, presumably due to carry-over of the essential oil in the initial screen. Sandalwood oil in this study is obtained from *Santalum spicatum* (Australian Sandalwood). There are two other kinds of Sandalwood oil: East Indian Sandalwood oil extracted from *Santalum album* and New Caledonian Sandalwood oil prepared from the wood of *Santalum austrocaledonicum* \[[@CR37]\]. Sandalwood oil from East Indian is widely studied as an attractive natural therapeutic for inflammatory skin diseases \[[@CR38]\]. On the other hand, Sandalwood oil from *Santalum spicatum* has high commercial value for applications in aromatherapy and for the production of cosmetics such as soaps, creams and powder \[[@CR37]\]. In this study, Sandalwood oil extracted from *Santalum spicatum* showed good activity against *S. aureus*, which demonstrated that it may be a promising antibacterial agent.

In this study, we carried out a high-throughput screen of essential oils for activity against stationary phase *S. aureus* and identified some highly active hits. While previous studies have identified some essential oils with activity against growing *S. aureus,* we identified additional new essential oils that have activity against both growing and non-growing stationary phase *S. aureus*. Since activity against non-growing bacteria seems to correlate with more effective treatment for persistent infections, the essential oils we identified that are highly active against non-growing stationary phase bacteria could be important for developing more effective treatment for persistent *S. aureus* infections. The potential limitations of the study include the mixed nature of the essential oils, lack of information on the active components of the active hits, lack of toxicity and pharmacokinetic data of the active essential oils in this study. The highly active essential oils form the basis for future studies to identify the active antimicrobial components and for further evaluation of the active hits in relevant animal models.

Conclusions {#Sec15}
===========

In summary, this is the first study of a large collection of 143 essential oils for activity against stationary phase *S. aureus* where we identified several promising essential oils. The top hits are Oregano, Cinnamon bark, Thyme white, Lemongrass (*Cymbopogon flexuosus*), Bandit "Thieves", Sandalwood oil, Health shield, Allspice, Amyris, Palmarosa. Meanwhile, we found in drug combination study with essential oil (Oregano) and antibiotics that some potent combinations such as Oregano plus quinolones or rifampin could effectively eradicate *S. aureus* persisters in vitro. Further studies should be carried out to identify the active components, evaluate safety, pharmacokinetics, and their activity to eradicate *S. aureus* persistent infections in animal models.
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**Additional file 1: Table S1.** Chemical compositions of the most active essential oils against *S. aureus*

CFU

:   Colony forming unit

CLSI

:   Clinical and laboratory standards institute

DMSO

:   Dimethyl sulfoxide

EO

:   Essential oil

MIC

:   Minimum inhibitory concentration

PBS

:   Phosphate-buffered saline

TSB

:   Tryptic soy broth
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